Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference16 articles.
1. Bergmann L, Berns B, Dalgleish AG, Von Euler M, Hecht TT et al (2010 Aug) Investigator-initiated trials of targeted oncology agents: why independent research is at risk? Ann Oncol 21(8):1573–1578.
https://doi.org/10.1093/annonc/mdq018
2. Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2018) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41–58.
https://doi.org/10.1038/nrd.2018.168
3. Directive 2001/20/EC of The European Parliament and of the Council, available at:
https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf
. Accessed 21 Feb 2019
4. Fuentes Camps I, Rodríguez A, Agustí A Non-commercial vs(2018) Commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee. Br J Clin Pharmacol 84:1384–1388.
https://doi.org/10.1111/bcp.13555
5. Montanaro N. Studi no-profit sui farmaci: è tempo di una normativa 2.0. Evidence, December 2014, volume 6, issue 12, e1000099, available at:
https://www.evidence.it/articoli/pdf/e1000099.pdf
. Accessed 21 Feb 2019